12 research outputs found
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)-and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamine.
Various approaches to the synthesis of all four stereoisomers of 2-(1H- imidazol-4-yl)cyclopropylamine (cyclopropylhistamine) are described. The rapid and convenient synthesis and resolution of trans-cyclopropylhistamine is reported. The absolute configuration of its enantiomers was determined by single-crystal X-ray crystallographic analysis. The distinct transcyclopropylhistamine enantiomers were tested for their activity and affinity on the histamine
The medicinal chemistry and therapeutic potentials of ligands of the histamine H₃ receptor.
Homologs of histamine as histamine H₃ receptor antagonists: a new potent and selective H₃ antagonist, 4(5)-(5-aminopentyl)-1H-imidazole.
Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?
Pharmacological analysis of immepip and imetit homologues. Further evidence for histamine H(3) receptor heterogeneity?
Following a previous report by our research group on discriminative properties of a series of aliphatic histamine homologues, we now studied immepip, imetit and its lower and higher sidechain homologues as ligands for the histamine